Assessment of plasma brain natriuretic peptide concentration in Boxers with arrhythmogenic right ventricular cardiomyopathy

American Journal of Veterinary Research

Volumn 66, Issue 12, 2005, Pages 2086-2089

  Baumwart, Ryan D ^a   Meurs, Kathryn M ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOG DISEASE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE PACING; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ANIMALS; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; DOG DISEASES; DOGS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; NATRIURETIC PEPTIDE, BRAIN; RADIOIMMUNOASSAY;

ANIMALIA; CANIS FAMILIARIS;

EID: 33645211692     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2005.66.2086     Document Type: Article

References (22)

1. Basso C, Fox FR, Meurs KM, et al. Arrhythmogenic right ventricular cardiomyopathy causing sudden cardiac death in boxer dogs: a new animal model of human disease. Circulation 2004; 109:1180-1185.
2. Meurs KM, Spier AW, Miller MW, et al. Familial ventricular arrhythmias in boxers. J Vet Intern Med 1999;13:437-439.
3. Harpster N. Boxer cardiomyopathy. A review of the long-term benefits of antiarrhythmic therapy. Vet Clin North Am Small Anim Pract 1991;21:989-1004.
4. Harpster N. Boxer cardiomyopathy. In: Kirk RW, ed. Current veterinary therapy VIII. Philadelphia: WB Saunders Co, 1983;329-337.
5. Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195-203.
6. Lang CC, Choy AM, Struthers AD. Atrial and brain natriuretic peptides: a dual natriuretic peptide system potentially involved in circulatory homeostasis. Clin Sci (Lond) 1992;83:519-527.
7. Cargill RI, Lipworth BJ. Atrial natriuretic peptide and brain natriuretic peptide in cor pulmonale. Hemodynamic and endocrine effects. Chest 1996;110:1220-1225.
8. Nagaya N, Nishikimi T, Uematsu M, et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 2000;102:865-870.
9. Tulevski II, Groenink M, van der Wall EE, et al. Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction. Heart 2001;86:27-30.
10. Mark DB, Felker GM. B type natriuretic peptide - a biomarker for all seasons? N Engl J Med 2004;350:718-720.
11. Sudoh T, Kangawa K, Minamino N, et al. A new natriuretic peptide in porcine brain. Nature 1988;332:78-81.
12. Matsuo K, Nishikimi T, Yutani C, et al. Diagnostic value of plasma levels of brain natriuretic peptide in arrhythmogenic right ventricular dysplasia. Circulation 1998;98:2433-2440.
13. Tanaka M, Hiroe M, Nishikawa T, et al. Cellular localization and structural characterization of natriuretic peptide-expressing ventricular myocytes from patients with dilated cardiomyopathy. J Histochem Cytochem 1994;42:1207-1214.
14. Moe GW, Grima EA, Wong NL, et al. Dual natriuretic peptide system in experimental heart failure. J Am Coll Cardiol 1993;22:891-898.
15. Asano K, Masuda K, Okumura M, et al. Plasma atrial and brain natriuretic peptide levels in dogs with congestive heart failure. J Vet Med Sci 1999;61:523-539.
16. MacDonald KA, Kittleson MD, Munro C, et al. Brain natriuretic peptide concentration in dogs with heart disease and congestive heart failure. J Vet Intern Med 2003;17:172-177.
17. Haggstrom J, Hansson K, Kvart C, et al. Relationship between different natriuretic peptides and severity of naturally acquired mitral regurgitation in dogs with chronic myxomatous valve disease. J Vet Cardiol 2000;2:7-16.
18. Chetboul V, Tessier-Vetzel D, Escriou C, et al. Diagnostic potential of natriuretic peptides in the occult phase of Golden Retriever muscular dystrophy cardiomyopathy. J Vet Intern Med 2004; 18:845-850.
19. Bonagura JB, Luis Fuentes V. Echocardiography. In: Ettinger SJ, Feldman EC, eds. Textbook of veterinary internal medicine. 5th ed. Philadelphia: WB Saunders Co, 2000;834-873.
20. Horio T, Kohno M, Takeda T. Effects of arginine vasopressin, angiotensin II and endothelin-1 on the release of brain natriuretic peptide in vivo and in vitro. Clin Exp Pharmacol Physiol 1992;19:575-582.
21. Meurs KM, Spier AW, Wright NA, et al. Use of the ambulatory electrocardiography for detection of ventricular premature complexes in healthy dogs. J Am Vet Med Assoc 2001;218:1291-1292.
22. McCullough PA, Omland T, Maisel AS. B-type natriuretic peptides: a diagnostic breakthrough for clinicians. Rev Cardiovasc Med 2003;4:72-80.